• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对髓鞘少突胶质细胞糖蛋白和髓鞘碱性蛋白的抗体反应取决于家族背景,并且在多发性家庭和散发性多发性硬化症中与人类白细胞抗原等位基因部分相关。

Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.

作者信息

Lutterotti Andreas, Reindl Markus, Gassner Christoph, Poustka Katharina, Schanda Kathrin, Deisenhammer Florian, Berger Thomas

机构信息

Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria.

出版信息

J Neuroimmunol. 2002 Oct;131(1-2):201-7. doi: 10.1016/s0165-5728(02)00271-0.

DOI:10.1016/s0165-5728(02)00271-0
PMID:12458053
Abstract

We investigated the association of the antibody response to myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) with human leukocyte antigen (HLA) class II alleles in 41 patients with sporadic multiple sclerosis (MS) and 12 multiplex MS families. We found significantly increased antibody response to MOG and MBP in MS patients without any difference to asymptomatic relatives. HLA DRB104 was associated with IgM reactivity to MOG in MS patients, and DRB115 and DRB5 with anti-MOG IgA among asymptomatic relatives. We conclude that antibody responses to MOG and MBP depend on familial background. Moreover, the humoral immune reactivity against MOG is partially under control of certain HLA class II alleles.

摘要

我们在41例散发型多发性硬化症(MS)患者和12个多发性MS家系中,研究了针对髓鞘少突胶质细胞糖蛋白(MOG)和髓鞘碱性蛋白(MBP)的抗体反应与人类白细胞抗原(HLA)II类等位基因之间的关联。我们发现MS患者对MOG和MBP的抗体反应显著增加,与无症状亲属相比无差异。HLA DRB104与MS患者对MOG的IgM反应性相关,而DRB115和DRB5与无症状亲属中的抗MOG IgA相关。我们得出结论,对MOG和MBP的抗体反应取决于家族背景。此外,针对MOG的体液免疫反应部分受某些HLA II类等位基因的控制。

相似文献

1
Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.对髓鞘少突胶质细胞糖蛋白和髓鞘碱性蛋白的抗体反应取决于家族背景,并且在多发性家庭和散发性多发性硬化症中与人类白细胞抗原等位基因部分相关。
J Neuroimmunol. 2002 Oct;131(1-2):201-7. doi: 10.1016/s0165-5728(02)00271-0.
2
Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy.X连锁肾上腺脑白质营养不良成年表型中对髓鞘少突胶质细胞糖蛋白的基因变异和体液免疫反应
J Neuroimmunol. 2003 Feb;135(1-2):148-53. doi: 10.1016/s0165-5728(02)00445-9.
3
Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.视神经脊髓型多发性硬化和传统型多发性硬化中T细胞对主要髓鞘蛋白衍生肽的反应性差异及健康对照
Tissue Antigens. 2001 May;57(5):447-56. doi: 10.1034/j.1399-0039.2001.057005447.x.
4
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.多发性硬化症中的抗髓鞘少突胶质细胞糖蛋白和抗髓鞘碱性蛋白抗体亚类
Mult Scler. 2001 Oct;7(5):285-9. doi: 10.1177/135245850100700503.
5
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.多发性硬化症及其他神经疾病中抗髓鞘少突胶质细胞糖蛋白和髓鞘碱性蛋白抗体的比较研究
Brain. 1999 Nov;122 ( Pt 11):2047-56. doi: 10.1093/brain/122.11.2047.
6
[Determination of autoantibody for myelin antigens in the serum of patients HLA-DQB1*0602 with multiple sclerosis].
Arq Neuropsiquiatr. 2003 Dec;61(4):968-73. doi: 10.1590/s0004-282x2003000600015. Epub 2004 Jan 6.
7
HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.HLA II类转基因小鼠证实了与多发性硬化症发病机制相关的髓鞘少突胶质细胞糖蛋白特异性免疫反应的限制。
Int Immunol. 2003 Apr;15(4):535-46. doi: 10.1093/intimm/dxg053.
8
T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.在HLA-DR4(DRB1*0401)转基因小鼠中鉴定出的人髓鞘少突胶质细胞糖蛋白的T细胞表位具有致脑炎作用,并由人B细胞呈递。
J Immunol. 2001 Dec 15;167(12):7119-25. doi: 10.4049/jimmunol.167.12.7119.
9
Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.复发缓解型多发性硬化症患者在疾病活动和免疫调节治疗不同阶段的血清抗髓鞘抗体水平
Dis Markers. 2005;21(2):49-55. doi: 10.1155/2005/826817.
10
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.人类白细胞抗原II类基因型不影响多发性硬化症患者的髓鞘反应性。
Cells. 2020 Dec 17;9(12):2703. doi: 10.3390/cells9122703.

引用本文的文献

1
Multiple Sclerosis: A Story of the Interaction Between Gut Microbiome and Components of the Immune System.多发性硬化症:肠道微生物群与免疫系统各组成部分之间的相互作用故事
Mol Neurobiol. 2025 Jun;62(6):7762-7775. doi: 10.1007/s12035-025-04728-5. Epub 2025 Feb 11.
2
Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses.抗髓鞘少突胶质细胞糖蛋白和人类白细胞抗原作为儿童及青少年多发性硬化症的标志物:关于诊断、临床表型及治疗反应
Mult Scler Int. 2018 Nov 22;2018:8487471. doi: 10.1155/2018/8487471. eCollection 2018.
3
Myelin oligodendrocyte glycoprotein antibodies in neurological disease.
髓鞘少突胶质细胞糖蛋白抗体与神经系统疾病
Nat Rev Neurol. 2019 Feb;15(2):89-102. doi: 10.1038/s41582-018-0112-x.
4
Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair.多发性硬化症:疾病机制以及髓鞘和轴突修复策略
Neurol Clin. 2018 Feb;36(1):1-11. doi: 10.1016/j.ncl.2017.08.002.
5
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?MOG 抗体阳性、AQP4 抗体阴性的视神经脊髓炎谱系疾病是否需要诊断为 NMOSD?
Neurol Neuroimmunol Neuroinflamm. 2015 Jan 22;2(1):e62. doi: 10.1212/NXI.0000000000000062. eCollection 2015 Feb.
6
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.抗髓鞘抗体与初次脱髓鞘事件患者的复发风险
J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):739-42. doi: 10.1136/jnnp.2005.077784.